120 related articles for article (PubMed ID: 20398540)
41. Nasal allergic response mediated by histamine H3 receptors in murine allergic rhinitis.
Nakaya M; Fukushima Y; Takeuchi N; Kaga K
Laryngoscope; 2005 Oct; 115(10):1778-84. PubMed ID: 16222194
[TBL] [Abstract][Full Text] [Related]
42. Clinical evaluation of lumiward immunoassay system for detection of specific IgE associated with allergic rhinitis.
Yamada K; Ohashi Y; Tanaka A; Kakinoki Y; Washio Y; Hayashi M; Kishimoto K; Nakai Y
Acta Otolaryngol Suppl; 1998; 538():169-77. PubMed ID: 9879417
[TBL] [Abstract][Full Text] [Related]
43. [Current pathophysiologic aspects of allergic rhinitis. I].
Albegger K
HNO; 1990 Sep; 38(9):305-8. PubMed ID: 2262346
[TBL] [Abstract][Full Text] [Related]
44. IL-15 prevents allergic rhinitis through reactivation of antigen-specific CD8+ cells.
Aoi N; Masuda T; Murakami D; Yajima T; Mizubuchi H; Yamada H; Kawauchi H; Yoshikai Y
J Allergy Clin Immunol; 2006 Jun; 117(6):1359-66. PubMed ID: 16750998
[TBL] [Abstract][Full Text] [Related]
45. Signals through CD40 play a critical role in the pathophysiology of Schistosoma mansoni egg antigen--induced allergic rhinitis in mice.
Hattori H; Okano M; Kariya S; Nishizaki K; Satoskar AR
Am J Rhinol; 2006; 20(2):165-9. PubMed ID: 16686380
[TBL] [Abstract][Full Text] [Related]
46. Diminished response to grass pollen allergen challenge in subjects with concurrent house dust mite allergy.
Reinartz SM; van Ree R; Versteeg SA; Zuidmeer L; van Drunen CM; Fokkens WJ
Rhinology; 2009 Jun; 47(2):192-8. PubMed ID: 19593978
[TBL] [Abstract][Full Text] [Related]
47. Local allergic rhinitis: a new entity, characterization and further studies.
Rondón C; Canto G; Blanca M
Curr Opin Allergy Clin Immunol; 2010 Feb; 10(1):1-7. PubMed ID: 20010094
[TBL] [Abstract][Full Text] [Related]
48. Contribution of allergen-specific and nonspecific nasal responses to early-phase and late-phase nasal responses.
Miyahara S; Miyahara N; Lucas JJ; Joetham A; Matsubara S; Ohnishi H; Dakhama A; Gelfand EW
J Allergy Clin Immunol; 2008 Mar; 121(3):718-24. PubMed ID: 18155286
[TBL] [Abstract][Full Text] [Related]
49. Local mucosal immunoglobulin E production: does allergy exist in non-allergic rhinitis?
Powe DG; Jones NS
Clin Exp Allergy; 2006 Nov; 36(11):1367-72. PubMed ID: 17083346
[TBL] [Abstract][Full Text] [Related]
50. Nasal hyperreactivity.
Gerth van Wijk RG; de Graaf-in 't Veld C; Garrelds IM
Rhinology; 1999 Jun; 37(2):50-5. PubMed ID: 10416248
[TBL] [Abstract][Full Text] [Related]
51. [Humoral mucosal immunity in allergic rhinitis].
Kramer MF; Jordan TR; Pfrogner E; Rasp G
Laryngorhinootologie; 2005 Jul; 84(7):503-10. PubMed ID: 16010632
[TBL] [Abstract][Full Text] [Related]
52. Skin prick reaction and nasal provocation response in diagnosis of nasal allergy to the house dust mite.
Kanthawatana S; Maturim W; Fooanan S; Trakultivakorn M
Ann Allergy Asthma Immunol; 1997 Nov; 79(5):427-30. PubMed ID: 9396976
[TBL] [Abstract][Full Text] [Related]
53. Relationship between allergen-specific skin testing and nasal provocation in patients with perennial rhinitis.
Small P; Biskin N
Ann Allergy; 1992 Apr; 68(4):331-3. PubMed ID: 1373048
[TBL] [Abstract][Full Text] [Related]
54. Aggravation of bronchial eosinophilia in mice by nasal and bronchial exposure to Staphylococcus aureus enterotoxin B.
Hellings PW; Hens G; Meyts I; Bullens D; Vanoirbeek J; Gevaert P; Jorissen M; Ceuppens JL; Bachert C
Clin Exp Allergy; 2006 Aug; 36(8):1063-71. PubMed ID: 16911362
[TBL] [Abstract][Full Text] [Related]
55. Nasal ECP patterns and specific immunotherapy in mite-allergic rhinitis patients.
Ferreira MB; Santos AS; Santos MC; Carlos ML; Barbosa MA; Carlos AG
Eur Ann Allergy Clin Immunol; 2005 Mar; 37(3):96-102. PubMed ID: 15918296
[TBL] [Abstract][Full Text] [Related]
56. Comparison between ovalbumin and ovalbumin peptide 323-339 responses in allergic mice: humoral and cellular aspects.
Sun LZ; Elsayed S; Aasen TB; Van Do T; Aardal NP; Florvaag E; Vaali K
Scand J Immunol; 2010 May; 71(5):329-35. PubMed ID: 20500683
[TBL] [Abstract][Full Text] [Related]
57. Clinical trial design, nasal allergen challenge models, and considerations of relevance to pediatrics, nasal polyposis, and different classes of medication.
Akerlund A; Andersson M; Leflein J; Lildholdt T; Mygind N
J Allergy Clin Immunol; 2005 Mar; 115(3 Suppl 1):S460-82. PubMed ID: 15746883
[TBL] [Abstract][Full Text] [Related]
58. Vascular endothelial growth factor in allergen-induced nasal inflammation.
Choi GS; Park HJ; Hur GY; Choi SJ; Shin SY; Ye YM; Park HS
Clin Exp Allergy; 2009 May; 39(5):655-61. PubMed ID: 19236408
[TBL] [Abstract][Full Text] [Related]
59. Nasal conditioning in perennial allergic rhinitis after nasal allergen challenge.
Rozsasi A; Leiacker R; Keck T
Clin Exp Allergy; 2004 Jul; 34(7):1099-104. PubMed ID: 15248856
[TBL] [Abstract][Full Text] [Related]
60. Impaired olfactory function in mice with allergic rhinitis.
Ozaki S; Toida K; Suzuki M; Nakamura Y; Ohno N; Ohashi T; Nakayama M; Hamajima Y; Inagaki A; Kitaoka K; Sei H; Murakami S
Auris Nasus Larynx; 2010 Oct; 37(5):575-83. PubMed ID: 20346605
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
